{
  "issued_date": "2013-12-19", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON355512", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2013/084", 
    "Audience": "Healthcare professionals", 
    "Published": "19 December 2013 at 11:30", 
    "Format": "Electronic", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Field Safety Notice", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con341229.pdf", 
      "filename": "downloads/9a2f53c8bcfbc2c381224e90de1cd36dabe80a05/con341229.pdf", 
      "original_filename": "con341229.pdf"
    }
  ], 
  "body": "## Device\n\nImplantable pacemakers manufactured by Sorin.\n\nREPLY \u2013 models D, DR, VDR, SR  \nESPRIT \u2013 models D, DR, S, SR\n\n## Problem\n\nRisk of loss of pacing due to overestimation of the time remaining to elective replacement indicator (ERI).\n\nSorin has received 8 reports where the residual longevity determined during follow-up was overestimated due to a software inaccuracy. This has arisen as a result of a difference between predicted and actual pacemaker battery depletion characteristics. All reports reached ERI within 4 to 5 years and involved pacemakers programmed with high pulse amplitude and width, combined with a high percentage of paced events.\n\nOver 20,000 pacemakers affected by this issue have been distributed in the UK since 2007.\n\nThe manufacturer has determined that the majority of affected pacemakers should not reach ERI within 8 years of implantation. However, it is important to note that this time may be significantly reduced for pacemakers with high programmed settings, for example in the case of pacing-dependent patients. It is also important to be aware that there are differences in nominal longevity between the pacemaker models (under Cenelec conditions of 70 min-1, 2.5V, 0.5ms). Reply DR and Reply D models have an expected nominal longevity of less than 8 years; being 7.1 and 7.4 years respectively, compared with Reply VDR and Reply SR at 9 years and 9.3 years respectively. Within the UK approximately 250 Reply DR and Reply D models were sold over 6 years ago. Early implants of these pacemaker models may be among the first to reach ERI, especially where they have a high percentage of pacing and/or high output settings.\n\nThe manufacturer will be issuing a new programmer software version to correct the quoted time to ERI and its presentation through the colour-coded gauge. All upgrades are expected to be completed in the UK within three months. However, the need for 6 monthly follow-up when the battery impedance reaches 3.5k\u2126 will remain.\n\nSorin distributed a [ASSET_TAG](#ASSET0) (40Kb) concerning this issue to affected customers on 20 November 2013.\n\n## Action\n\nReview the last follow-up exam for all patients implanted with an affected pacemaker.\n\nSchedule three-month follow up:  \n  \n  * for those patients whose battery impedance displayed a value greater than or equal to 3.5k\u03a9. Priority should be given to pacemaker-dependent patients and those with high programmed settings  \n  * if the last follow up was carried out without the use of a programmer and the magnet rate was less than 95 min-1.  \n  \nOnce Sorin has upgraded your programmer software:  \n  \n  * obtain an accurate residual longevity reading by following up all patients within three months  \n  * continue with six-monthly follow-ups where pacemaker battery impedance becomes greater than or equal to 3.5k\u03a9.  \n  \n### Action by:\n\nAll cardiologists and cardiac physiologists who manage patients implanted with pacemakers.\n\n## Distribution\n\nThis MDA has been sent to:  \n  \n  * Care Quality Commission (CQC) (headquarters) for information  \n  * Clinical commissioning groups (CCGs)  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * Local authorities in Scotland (equipment coordinators)  \n  * NHS boards and trusts in Wales (chief executives)  \n  * NHS boards in Scotland (equipment coordinators)  \n  * NHS trusts in England (chief executives)  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment.  \nBelow is a suggested list of recipients. \n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * Cardiac laboratory technicians  \n  * Cardiac pacing technicians  \n  * Cardiac physiologists  \n  * Cardiologists  \n  * Cardiology departments  \n  * Cardiology nurses  \n  * Cardiology, directors of  \n  * Clinical governance leads  \n  * Medical directors  \n  * Nursing executive directors  \n  * Risk managers  \n  \nNHS England area teams\u00a0  \nCAS liaison officers for onward distribution to all relevant staff including:  \n  \n  * General practitioners  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)\u00a0  \nThis alert should be read by:  \n  \n  * Private medical practitioners  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health\u2019s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk) and requesting this facility.\n\n## Manufacturer Contact\n\nElodie Vincent  \nSorin CRM  \nParc d'affaires NOVEOS  \n4, Avenue R\u00e9aumur  \n92143 Clamart Cedex  \n  \nTel: +33 1 46 01 36 65  \nEmail: [crm.complaints@sorin.com](mailto:crm.complaints@sorin.com)\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at:[dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk). \n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2013/084 or 2013/011/021/291/004\n\nTechnical aspects  \nMichelle Kelly or Simon Holmes or Hazel Randall  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel: 020 3080 7145 / 7240 / 7287  \nFax: 020 8754 3965  \nEmail: [michelle.kelly@mhra.gsi.gov.uk](mailto:michelle.kelly@mhra.gsi.gov.uk), [simon.holmes@mhra.gsi.gov.uk](mailto:simon.holmes@mhra.gsi.gov.uk) or [hazel.randall@mhra.gsi.gov.uk](mailto:hazel.randall@mhra.gsi.gov.uk)\n\nClinical aspects  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4, 151 Buckingham Palace Road, London SW1W 9SZ  \nTel: 020 3080 7032 / 7248  \nFax: 020 8754 3965  \nEmail: [kayleigh.purdon@mhra.gsi.gov.uk](mailto:kayleigh.purdon@mhra.gsi.gov.uk)\n\n### How to report adverse incidents\n\nPlease report via our website:\u00a0[Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found\u00a0[on the CAS website](https://www.cas.dh.gov.uk/Home.aspx)\u00a0(external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.  \n  \nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings, Stormont Estate  \nDundonald BT4 3SQ  \nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail:\u00a0[NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the\u00a0[NIAIC website](http://www.dhsspsni.gov.uk/niaic)\u00a0(external link)  \nFurther information about SABS can be found\u00a0[on the SABS website](http://sabs.dhsspsni.gov.uk/)\u00a0(external link)\n\n## Scotland\n\nAll requests regarding return, replacement or modification of the devices mentioned in this alert should be directed to the relevant supplier or manufacturer.  \n  \nOther enquiries and adverse incident reports in Scotland should be addressed to:  \n  \nIncident Reporting and Investigation Centre  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB  \nTel: 0131 275 7575  \nFax: 0131 314 0722  \nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Incident Reporting and Investigation Centre](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 5801  \nEmail:\u00a0[Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><span>Implantable pacemakers manufactured by Sorin.</span></p>\n\n<p><span>REPLY &#8211; models D, DR, VDR, SR<br>\nESPRIT &#8211; models D, DR, S, SR</span></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><span>Risk of loss of pacing due to overestimation of the time remaining to elective replacement indicator (ERI).</span></p>\n\n<p>Sorin has received 8 reports where the residual longevity determined during follow-up was overestimated due to a software inaccuracy. This has arisen as a result of a difference between predicted and actual pacemaker battery depletion characteristics. All reports reached ERI within 4 to 5 years and involved pacemakers programmed with high pulse amplitude and width, combined with a high percentage of paced events.</p>\n\n<p>Over 20,000 pacemakers affected by this issue have been distributed in the UK since 2007.</p>\n\n<p>The manufacturer has determined that the majority of affected pacemakers should not reach ERI within 8 years of implantation. However, it is important to note that this time may be significantly reduced for pacemakers with high programmed settings, for example in the case of pacing-dependent patients. It is also important to be aware that there are differences in nominal longevity between the pacemaker models (under Cenelec conditions of 70 min-1, 2.5V, 0.5ms). Reply DR and Reply D models have an expected nominal longevity of less than 8 years; being 7.1 and 7.4 years respectively, compared with Reply VDR and Reply SR at 9 years and 9.3 years respectively. Within the UK approximately 250 Reply DR and Reply D models were sold over 6 years ago. Early implants of these pacemaker models may be among the first to reach ERI, especially where they have a high percentage of pacing and/or high output settings.</p>\n\n<p>The manufacturer will be issuing a new programmer software version to correct the quoted time to ERI and its presentation through the colour-coded gauge. All upgrades are expected to be completed in the UK within three months. However, the need for 6 monthly follow-up when the battery impedance reaches 3.5k&#8486; will remain.</p>\n\n<p>Sorin distributed a <a href=\"#ASSET0\">ASSET_TAG</a> (40Kb) concerning this issue to affected customers on 20 November 2013.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<p>Review the last follow-up exam for all patients implanted with an affected pacemaker.</p>\n\n<p>Schedule three-month follow up:</p>\n\n<ul>\n<li>for those patients whose battery impedance displayed a value greater than or equal to 3.5k&#937;. Priority should be given to pacemaker-dependent patients and those with high programmed settings</li>\n\n<li>if the last follow up was carried out without the use of a programmer and the magnet rate was less than 95 min-1.</li>\n</ul>\n\n<p>Once Sorin has upgraded your programmer software:</p>\n\n<ul>\n<li>obtain an accurate residual longevity reading by following up all patients within three months</li>\n\n<li>continue with six-monthly follow-ups where pacemaker battery impedance becomes greater than or equal to 3.5k&#937;.</li>\n</ul>\n\n<h3>Action by:</h3>\n\n<p>All cardiologists and cardiac physiologists who manage patients implanted with pacemakers.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to:</p>\n\n<ul>\n<li>Care Quality Commission (CQC) (headquarters) for information</li>\n\n<li>Clinical commissioning groups (CCGs)</li>\n\n<li>HSC trusts in Northern Ireland (chief executives)</li>\n\n<li>Local authorities in Scotland (equipment coordinators)</li>\n\n<li>NHS boards and trusts in Wales (chief executives)</li>\n\n<li>NHS boards in Scotland (equipment coordinators)</li>\n\n<li>NHS trusts in England (chief executives)</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\nPlease bring this notice to the attention of relevant employees in your establishment.<br>\nBelow is a suggested list of recipients. \n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Cardiac laboratory technicians</li>\n\n<li>Cardiac pacing technicians</li>\n\n<li>Cardiac physiologists</li>\n\n<li>Cardiologists</li>\n\n<li>Cardiology departments</li>\n\n<li>Cardiology nurses</li>\n\n<li>Cardiology, directors of</li>\n\n<li>Clinical governance leads</li>\n\n<li>Medical directors</li>\n\n<li>Nursing executive directors</li>\n\n<li>Risk managers</li>\n</ul>\n\n<p><span>NHS England area teams&#160;</span><br>\nCAS liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>General practitioners</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p><span>Establishments registered with the Care Quality Commission (CQC) (England only)&#160;</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Private medical practitioners</li>\n</ul>\n\n<p>Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health&#8217;s Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\">safetyalerts@dh.gsi.gov.uk</a> and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\tElodie Vincent<br>\nSorin CRM<br>\nParc d'affaires NOVEOS<br>\n4, Avenue R&#233;aumur<br>\n92143 Clamart Cedex<br>\n<br>\nTel: +33 1 46 01 36 65<br>\nEmail: <a href=\"mailto:crm.complaints@sorin.com\">crm.complaints@sorin.com</a>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\tIf you have any comments or feedback on this Medical Device Alert please email us at:<a href=\"mailto:dts@mhra.gsi.gov.uk\">dts@mhra.gsi.gov.uk</a>.\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2013/084</span> or <span>2013/011/021/291/004</span></p>\n\n<p><span>Technical aspects</span><br>\nMichelle Kelly or Simon Holmes or Hazel Randall<br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel: 020 3080 7145 / 7240 / 7287<br>\nFax: 020 8754 3965<br>\nEmail: <a href=\"mailto:michelle.kelly@mhra.gsi.gov.uk\">michelle.kelly@mhra.gsi.gov.uk</a>, <a href=\"mailto:simon.holmes@mhra.gsi.gov.uk\">simon.holmes@mhra.gsi.gov.uk</a> or <a href=\"mailto:hazel.randall@mhra.gsi.gov.uk\">hazel.randall@mhra.gsi.gov.uk</a></p>\n\n<p><span>Clinical aspects</span><br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4, 151 Buckingham Palace Road, London SW1W 9SZ<br>\nTel: 020 3080 7032 / 7248<br>\nFax: 020 8754 3965<br>\nEmail: <a href=\"mailto:kayleigh.purdon@mhra.gsi.gov.uk\">kayleigh.purdon@mhra.gsi.gov.uk</a></p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website:&#160;<a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found&#160;<a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a>&#160;(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.<br>\n<br>\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings, Stormont Estate<br>\nDundonald BT4 3SQ<br>\nTel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail:&#160;<a href=\"mailto:NIAIC@dhsspsni.gov.uk\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the&#160;<a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a>&#160;(external link)<br>\nFurther information about SABS can be found&#160;<a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>&#160;(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>All requests regarding return, replacement or modification of the devices mentioned in this alert should be directed to the relevant supplier or manufacturer.<br>\n<br>\nOther enquiries and adverse incident reports in Scotland should be addressed to:<br>\n<br>\nIncident Reporting and Investigation Centre<br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB<br>\nTel: 0131 275 7575<br>\nFax: 0131 314 0722<br>\nEmail: <a href=\"mailto:nss.iric@nhs.net\">nss.iric@nhs.net</a></p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\">Incident Reporting and Investigation Centre</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 5801<br>\nEmail:&#160;<a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: Implantable pacemakers manufactured by Sorin (MDA/2013/084)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": []
}